开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Muhammad Ali Khan
Hepatitis B Virus (HBV) is the most prevalent cause of chronic liver disease in the developing world. It is often an overlooked entity as it does not garner as much attention as other diseases in this day and age. Flawed perceptions, myths and non pragmatic vaccination programs have led to a dire situation. Things have pretty much remained stagnant with respect to HBV in the last few decades. With no new drugs or interventions in sight for HBV, it is time to rethink strategy and come up with novel ideas and solutions to tackle this epidemic once in for all.